Sandra E. Dillahunt

Array ( [id] => 9262157 [patent_doc_number] => 20130344086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'STABLE AND SOLUBLE ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/011831 [patent_app_country] => US [patent_app_date] => 2013-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22085 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14011831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9396498 [patent_doc_number] => 20140093903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-03 [patent_title] => 'METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT' [patent_app_type] => utility [patent_app_number] => 14/011715 [patent_app_country] => US [patent_app_date] => 2013-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 62755 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14011715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10421046 [patent_doc_number] => 20150306058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-29 [patent_title] => 'COMPOSITION COMPRISING A SINGLE VARIABLE DOMAIN AND CAMOSTAT MESYLATE (CM)' [patent_app_type] => utility [patent_app_number] => 14/422706 [patent_app_country] => US [patent_app_date] => 2013-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5325 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14422706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9318356 [patent_doc_number] => 20140050694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-20 [patent_title] => 'Method of Treating Transplant Rejection and Autoimmune Diseases' [patent_app_type] => utility [patent_app_number] => 13/969996 [patent_app_country] => US [patent_app_date] => 2013-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21393 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13969996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10325765 [patent_doc_number] => 20150210770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-30 [patent_title] => 'THERAPEUTIC AND DIAGNOSTIC TARGET' [patent_app_type] => utility [patent_app_number] => 14/418282 [patent_app_country] => US [patent_app_date] => 2013-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 34826 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14418282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10265950 [patent_doc_number] => 20150150947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-04 [patent_title] => 'TREATING INFLAMMATION USING SERELAXIN' [patent_app_type] => utility [patent_app_number] => 14/418107 [patent_app_country] => US [patent_app_date] => 2013-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12157 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14418107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15784893 [patent_doc_number] => 10626153 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-21 [patent_title] => HMGB1 variants and uses thereof [patent_app_type] => utility [patent_app_number] => 14/416128 [patent_app_country] => US [patent_app_date] => 2013-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 36 [patent_no_of_words] => 11318 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10318916 [patent_doc_number] => 20150203919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-23 [patent_title] => 'METHODS FOR PREDICTING THE SURVIVAL TIME AND TREATMENT RESPONSIVENESS OF A PATIENT SUFFERING FROM A SOLID CANCER WITH A SIGNATURE OF AT LEAST 7 GENES' [patent_app_type] => utility [patent_app_number] => 14/413856 [patent_app_country] => US [patent_app_date] => 2013-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 13628 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14413856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9204932 [patent_doc_number] => 20140004109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'Methods Of Reducing Eosinophil Levels' [patent_app_type] => utility [patent_app_number] => 13/934271 [patent_app_country] => US [patent_app_date] => 2013-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 33023 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13934271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9211600 [patent_doc_number] => 20140010777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'METHODS FOR DETERMINING PERSONALIZED TREATMENT COMPOSITIONS FOR PROSTATE CANCER AND BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 13/935355 [patent_app_country] => US [patent_app_date] => 2013-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8718 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13935355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10339185 [patent_doc_number] => 20150224190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-13 [patent_title] => 'Combination of a phosphoinositide 3-kinase inhibitor and an inhibitor of the IL-8/CXCR interaction' [patent_app_type] => utility [patent_app_number] => 14/410598 [patent_app_country] => US [patent_app_date] => 2013-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16630 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14410598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9211655 [patent_doc_number] => 20140010832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'PROTEIN-BINDING PEPTIDE ISOLATED FROM PLACENTA GROWTH FACTOR' [patent_app_type] => utility [patent_app_number] => 13/933444 [patent_app_country] => US [patent_app_date] => 2013-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19760 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13933444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11191553 [patent_doc_number] => 09422354 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-23 [patent_title] => 'Process for purification of recombinant granulocyte colony stimulating factor (rHu GCSF)' [patent_app_type] => utility [patent_app_number] => 13/921891 [patent_app_country] => US [patent_app_date] => 2013-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13801 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13921891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9330063 [patent_doc_number] => 20140056844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'METHODS OF METABOLIC TARGETING CANCER CELLS USING CHEMO- AND IMMUNOTHERAPY FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 13/911977 [patent_app_country] => US [patent_app_date] => 2013-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15931 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13911977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11521651 [patent_doc_number] => 09605038 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-28 [patent_title] => 'Fusion peptide comprising dhFas-1 domain and MMP substrate and use thereof for preventing and treating rheumatoid arthritis' [patent_app_type] => utility [patent_app_number] => 13/907327 [patent_app_country] => US [patent_app_date] => 2013-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 17169 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13907327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10255016 [patent_doc_number] => 20150140011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'IL-6 BINDING MOLECULES' [patent_app_type] => utility [patent_app_number] => 14/403135 [patent_app_country] => US [patent_app_date] => 2013-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 38793 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10247257 [patent_doc_number] => 20150132253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-14 [patent_title] => 'COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/401899 [patent_app_country] => US [patent_app_date] => 2013-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 29630 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401899 [rel_patent_id] =>[rel_patent_doc_number] =>)